Hal E. Schneider

Boston Children's Hospital

Papers

1

Total Citations

417

H-Index

1

About

Hal E. Schneider is a leading molecular geneticist whose work has fundamentally advanced our understanding of ribosomopathies—diseases caused by defects in ribosome biogenesis. His research centers on the genetic basis of Diamond-Blackfan Anemia (DBA), a rare bone marrow failure syndrome, and its unexpected links to congenital malformations. Schneider’s most influential contribution, a landmark 2008 study with over 417 citations, identified mutations in ribosomal proteins L5 and L11 as causative factors for DBA. Crucially, this work revealed that these same mutations are associated with cleft palate and abnormal thumbs, establishing a direct molecular connection between ribosomal dysfunction and developmental anomalies. By demonstrating that specific ribosomal protein defects can produce both hematologic and craniofacial phenotypes, Schneider reshaped the paradigm of how ribosome assembly errors manifest as complex human disease. His findings have not only guided clinical diagnostics for DBA patients but also opened new avenues for understanding the role of ribosomes in embryonic development. Schneider’s research continues to bridge the gap between basic ribosome biology and clinical genetics, making him a pivotal figure in the field of inherited bone marrow disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
417
Total Citations
417
Avg Citations/Paper
🏆 Most Cited Paper
Ribosomal Protein L5 and L11 Mutations Are Associated with Cleft Palate and Abnormal Thumbs in Diamond-Blackfan Anemia Patients
417 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Boston Children's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago